Brisbane-based vaccine patch company Vaxxas is developing the first room temperature-stable needleless vaccine for one of the world’s most common cold-like diseases, weeks after launching efforts to raise $100...
A Brisbane biotech that makes needle free vaccine delivery patches has been tapped by a global charity to help fight typhoid, the life-threatening disease that infects millions of people...
A multi-million-dollar manufacturing facility capable of producing needle-free vaccine patches in Queensland within the next five years has been completed by Brisbane-based biotechnology company Vaxxas. The Vaxxas Biomedical Facility,...